Revolutionizing Hepatitis C Treatment: The Tran...

By Rene Pretorius

May 14, 2025

The advent of direct-acting antivirals (DAAs) has redefined the landscape of hepatitis C (HCV) treatment, offering unpre...
MR-107A-02: Revolutionizing Non-Opioid Pain Management with Viatris’ Breakthr...
Prevention Valuation: Fund Health, Not Just Savings
FDA AI Drug Approval
Trump Science Publishing Critique: Analyzing Political Interference and Metho...
South Africa NHI Bill Court Ruling Calls for Scrutiny
Implementing Health Technology Assessment in Oman
Wegovy CVS Deal: Hybrid Market Access Strategy Insights
Empowering Health: The Role of Self-Care and NCDs in Global Health Policy
Assessing Risks and Opportunities: The Impact of the CDC Hepatitis Lab Closure
Journavx for Pain Management: Toward Affordability and Access
Defunding Scientific Research: Implications and Misconceptions in GawandeR...
Optimizing Value-Based Drug Pricing in Japan with MARIE Framework